Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Safety and Effectiveness of The Paragonix™ SherpaPak Cardiac Transport System in Donation After Circulatory Death Heart Transplantation

NCT05038943 is registered in ClinicalTrials.gov with University of Nebraska as lead sponsor.

NCT NCT05038943
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05038943 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Safety and Effectiveness of The Paragonix™ SherpaPak Cardiac Transport System in Donation After Circulatory Death Heart Transplantation
Lead sponsor
University of Nebraska
Phase
Not applicable
Overall status
Completed
Start date
September 15, 2021
Completion date
April 8, 2022
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

determination of death, extracorporeal membrane oxygenation, heart transplant failure, outcomes research